Defilade Capital Management manages private investment funds, including onshore and offshore pooled vehicles, primarily targeting institutional investors, pension plans, endowments, and high-net-worth individuals. Defilade pursues a long/short equity investment strategy focused on the healthcare, life sciences, and technology sectors, aiming to generate superior risk-adjusted returns while preserving capital. Defilade operates on a discretionary basis, making all trading and investment decisions on behalf of the funds. The firm utilizes a multi-layered risk management framework and employs quantitative tools, financial models, and alternative data sources to analyze market trends and execute investments.
| Portfolio Value | Annual Fee |
|---|---|
| Any | 2.00% |
Defilade Capital Management charges an annual management fee of 2% and an annual 20% performance-based incentive allocation. Fees may be waived, reduced, or calculated differently for certain investors at the firm's discretion.